secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001609550-25-000018
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q1 rev $201.3M (+23% YoY), EPS $0.10; raises FY EPS guidance to $2.20-$2.30
--------------------------------------------------------------------------------

- Revenue $201.3M, up 23% YoY; U.S. revenue $193.6M (+24%), OUS $7.7M (-6%).
- Net income $3.0M (diluted EPS $0.10) vs net loss $10.0M ($0.34 loss) in Q1 2024.
- Adjusted EBITDA $33.2M, up from $11.9M; operating loss improved 90% to $1.5M.
- Surpassed 100,000 patients on Inspire therapy; Inspire V system launch starting in U.S. May 2025.
- FY 2025 revenue guidance maintained $940-955M; EPS guidance raised to $2.20-$2.30 (from $2.10-$2.20).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955025000018/0001609550-25-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955025000018/insp-20250505.htm
  HTML page:      https://secwatch.observer/filing/0001609550-25-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer